Core Viewpoint - Alexander's, Inc. is set to release its quarterly report for Q2 2024 on August 5, 2024, prior to the market opening, with a subsequent earnings conference call scheduled for August 6, 2024 [1][2]. Group 1: Earnings Report and Conference Call - The quarterly report on Form 10-Q for the quarter ended June 30, 2024, will be filed with the U.S. Securities and Exchange Commission [1]. - Vornado Realty Trust, which manages Alexander's operations, will host the earnings conference call on August 6, 2024, at 10:00 a.m. ET [1]. - The conference call can be accessed via a domestic number (888-317-6003) and an international number (412-317-6061) with a passcode of 8799771 [2]. Group 2: Company Overview - Alexander's, Inc. operates as a real estate investment trust (REIT) with five properties located in the New York City metropolitan area [2].

Core Viewpoint - Office REITs have shown modest gains in 2023, with an average return of 5.23%, significantly lower than the S&P 500's 18.55% and Nasdaq 100's 21.20% [2][3] Performance Summary - Year-to-date performance of various REIT sectors shows Cannabis at 13.33%, Healthcare at 11.68%, and Office at 5.23%, while the Equity REIT Index averages only 1.07% [3] - The WFH trend has led to a permanent decrease in demand for commercial office space, contributing to increased defaults in commercial real estate loans, particularly office-related loans [4] Company Overview - Alexanders, Inc. (ALX) is a small-cap REIT with a market cap of $1.14 billion, primarily focused on office and retail properties in New York City [4] - ALX has a portfolio of 2.455 million square feet with a 92.5% occupancy rate for office and retail spaces and 96.8% for residential properties as of March 31 [4] Financial Performance - ALX reported Q1 2024 rental revenue of $61.4 million, a 16.1% increase from Q1 2023, while net income rose by 43.8% to $16.1 million [10] - The company experienced a significant drop in cash from financing, down 99.6% year-over-year, due to unusual treasury sales in the previous year [10] Growth Metrics - ALX's FFO (Funds From Operations) has shown a declining trend over the past four years, with a CAGR of -5.03% [12] - The stock price has decreased by 41.27% over the past decade, indicating a bearish long-term trend despite short-term gains [9] Balance Sheet Metrics - ALX has a liquidity ratio of 1.20 and a debt ratio of 50%, with total debts of $1.093 billion against cash and cash equivalents of $536 million [14] - The company has a high Debt/EBITDA ratio of 10.0, indicating significant leverage [14] Dividend Metrics - ALX maintains a quarterly dividend of $4.50, with a payout ratio of 114%, which is considered unsustainable [16] - The company has not cut its dividend during the pandemic, but the current payout ratio raises concerns about future sustainability [16] Valuation Metrics - ALX is currently priced 9.6% above its estimated NAV, with a dividend score of 8.01 and a price/FFO ratio of 17.5 [17] Investor Sentiment - Analysts have mixed ratings on ALX, with one analyst maintaining a Sell rating and a price target of $145, implying a potential downside of 34.5% [19]

holicow/E+ via Getty Images If you have read my recent articles, you know that I am expecting a major sell-off in REITs over the next 2 - 5 years. As the graph below shows, the REIT rally that began in October, fueled by expectations of multiple rate cuts by the Fed, is showing signs of fizzling out. VNQ price chart (Seeking Alpha Premium) This is a 180-degree about-face from my outlook at the beginning of this year. I base this new expectation primarily on the technicals, but also on a looming crisi ...

DNY59 Topline Summary and Update ALX Oncology (NASDAQ:ALXO) is a cancer-focused biotech I've expressed deep skepticism in over the course of various articles, stating unequivocally that I did not feel that the risk to reward ratio was appropriate at the billion-plus market cap that the company was commanding as a phase 2 entity. They had generated compelling findings in their early trial readouts, but the CD47-based approach carries too much baggage for me to get too excited. Since then, the company's va ...

ALX Resources Corp. Receives Analytical Results from the Gibbons Creek Uranium Project, Athabasca Basin, SaskatchewanJune 13, 2024 7:30 AM EDT | Source: ALX Resources Corp.Vancouver, British Columbia--(Newsfile Corp. - June 13, 2024) - ALX Resources Corp. (TSXV: AL) (FSE: 6LLN) (OTC: ALXEF) ("ALX" or the "Company") is pleased to announce the results of the 2024 winter drilling program and upcoming summer 2024 exploration plans at its Gibbons Creek Uranium Project ("Gibbons Creek", or the "Proj ...

SOUTH SAN FRANCISCO, Calif., May 29, 2024 (GLOBE NEWSWIRE) -- ALX Oncology Holdings Inc., (“ALX Oncology” or “the Company”) (Nasdaq: ALXO), an immuno-oncology company developing therapies that block the CD47 immune checkpoint pathway, today announced that management will participate in the Jefferies Global Healthcare Conference. Details are as follows: Format: Fireside chat with analyst, Michael Yee and 1x1 Investor MeetingsDate: Wednesday, June 5, 2024 Time: 1:00 PM ET Location: New York, NY Webcast link: ...

Core Viewpoint - The article discusses the potential investment opportunities in high-yield dividend stocks that are currently out of favor with Wall Street analysts, suggesting that these stocks may be worth investigating for contrarian investors [1][2]. Group 1: High-Yield Dividend Stocks - Seven dividend-paying stocks with yields up to 12.9% are highlighted, all of which are disliked by Wall Street analysts, indicating a potential contrarian investment opportunity [2]. - Xerox (XRX) offers a 7.2% yield, but its dividend has remained stagnant at $0.25 per share since 2017, reflecting a lack of growth and a prolonged downtrend in stock value, losing 25% in 2024 [3]. - Western Union (WU) has a 7.1% yield and has struggled against competitors, with a frozen dividend for several years. Despite a challenging outlook, shares have increased by 25% from spring 2023 lows, and the company is showing signs of progress with its "Evolve 2025" initiative [4][5]. - Alexander's (ALX) is an office REIT with an 8.3% yield, which has seen its stock value drop significantly due to COVID-19. The company has improved its funds from operations (FFO) coverage in Q1 2024, indicating potential recovery [6][7]. - Peakstone Realty Trust (PKST) has a 6.0% yield and has faced a nearly 60% decline since going public in April 2023. The company is repositioning its portfolio, which may improve its long-term prospects [8][9]. - National Storage Affiliates Trust (NSA) also has a 6.0% yield and has been affected by high home prices and interest rates. However, its dividend is well-covered at 89% of estimated 2024 FFO, and stock prices have been gradually improving [10]. - Buckle (BKE) offers a 10.0% yield but has a bearish analyst sentiment with one Hold and one Sell. Despite weaker operations, the company is expected to resume profit growth next fiscal year [11]. - Prospect Capital (PSEC) has a 12.9% yield but a poor track record with multiple dividend cuts. It trades at a significant discount to NAV, indicating deep value pricing despite analyst pessimism [12].

分组1 - Alexander's reported quarterly funds from operations (FFO) of $4.98 per share, missing the Zacks Consensus Estimate of $6.41 per share, and showing an increase from $3.63 per share a year ago, resulting in an FFO surprise of -22.31% [1] - The company posted revenues of $61.4 million for the quarter ended March 2024, missing the Zacks Consensus Estimate by 13.40%, compared to year-ago revenues of $52.94 million [1] - Over the last four quarters, Alexander's has surpassed consensus FFO estimates two times and topped consensus revenue estimates three times [1] 分组2 - The stock has added about 0.1% since the beginning of the year, underperforming the S&P 500's gain of 7.5% [2] - The current consensus FFO estimate for the coming quarter is $2.87 on $54.9 million in revenues, and for the current fiscal year, it is $14.86 on $235.5 million in revenues [4] - The Zacks Industry Rank for REIT and Equity Trust - Other is currently in the top 40% of over 250 Zacks industries, indicating a favorable outlook compared to the bottom 50% [4]

Core Insights - Alexander's, Inc. reported a net income of $16.1 million, or $3.14 per diluted share, for the quarter ended March 31, 2024, an increase from $11.2 million, or $2.19 per diluted share, for the same quarter in 2023 [1][3] - Funds from operations (FFO) for the quarter was $25.5 million, or $4.98 per diluted share, compared to $18.6 million, or $3.63 per diluted share, for the quarter ended March 31, 2023 [1][3] - The company operates as a real estate investment trust (REIT) with five properties located in New York City [1] Financial Performance - Revenues for the quarter ended March 31, 2024, were $61.4 million, up from $52.9 million in the same quarter of 2023 [3][4] - The weighted average shares outstanding for basic and diluted calculations were 5,130,678 for both 2024 and 2023 [3][4] - Depreciation and amortization of real property for the quarter was $9.4 million, compared to $7.4 million in the previous year [4]

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark one) ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: March 31, 2024 Or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from: to Commission File Number: 001-06064 ALEXANDERS INC (Exact name of registrant as specified in its charter) Delaware 51-0100517 | --- | --- | |-------------- ...